Guidelines on the use of Bone Modifying Agents in Patients with Breast Cancer – DFCI Breast Oncology Center Dana-Farber’s Breast Oncology Center shared on X: “Our consensus-based treatment guidelines on the use of Bone Modifying Agents in Patients with Breast Cancer are now up, check them out here.” . Source: Dana-Farber’s Breast Oncology Center/X Insight Bone Modifying Agents Breast Cancer cancer Dana-Farber’s Breast Oncology Center OncoDaily Oncology
